Acadia Healthcare Company, Inc. $ACHC Stock Position Lifted by First Trust Advisors LP

First Trust Advisors LP grew its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 73.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,689,442 shares of the company’s stock after purchasing an additional 712,852 shares during the period. First Trust Advisors LP’s holdings in Acadia Healthcare were worth $39,516,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. EverSource Wealth Advisors LLC lifted its holdings in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN increased its stake in Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after buying an additional 1,510 shares during the period. Bayforest Capital Ltd bought a new stake in shares of Acadia Healthcare during the 4th quarter worth about $52,000. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after buying an additional 2,698 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its stake in shares of Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after acquiring an additional 5,203 shares during the period.

Analyst Ratings Changes

A number of research firms recently commented on ACHC. Royal Bank Of Canada raised their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research report on Monday, May 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. KeyCorp lifted their price target on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Finally, Guggenheim upped their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $28.69.

Acadia Healthcare Trading Down 5.8%

Shares of NASDAQ ACHC opened at $32.50 on Tuesday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $35.83. The company has a market cap of $2.99 billion, a price-to-earnings ratio of -2.66, a P/E/G ratio of 11.51 and a beta of 0.64. The business has a fifty day simple moving average of $27.78 and a 200-day simple moving average of $23.36.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.